• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation.经皮经肝门静脉栓塞术与单侧门静脉结扎术的比较。
World J Gastroenterol. 2012 May 21;18(19):2371-6. doi: 10.3748/wjg.v18.i19.2371.
2
Percutaneous transhepatic portal embolization using foam ethanolamine oleate and carbon dioxide (CO₂): a pilot study.使用油酸乙醇胺泡沫和二氧化碳(CO₂)进行经皮经肝门静脉栓塞术:一项初步研究。
Acta Radiol. 2015 Nov;56(11):1361-7. doi: 10.1177/0284185115590285. Epub 2015 Jun 24.
3
Hepatic hypertrophy and hemodynamics of portal venous flow after percutaneous transhepatic portal embolization.经皮经肝门静脉栓塞术后肝脏肥大及门静脉血流动力学变化
BMC Surg. 2019 Feb 18;19(1):23. doi: 10.1186/s12893-019-0486-8.
4
[Preoperative percutaneous transhepatic portal vein embolization to extend the indications for hepatectomy and to increase the safety of extended hepatectomy for hepatocellular carcinoma].[术前经皮经肝门静脉栓塞术以扩大肝癌肝切除术的适应证并提高扩大肝切除术的安全性]
Nihon Geka Gakkai Zasshi. 1992 Oct;93(10):1317-23.
5
Course before and after percutaneous transhepatic portal vein embolization of a patient with cholangiocarcinoma monitored by scintigraphy with Tc-99m galactosyl human serum albumin.通过用Tc-99m半乳糖基人血清白蛋白闪烁显像监测的胆管癌患者经皮经肝门静脉栓塞前后的病程
Ann Nucl Med. 2000 Jun;14(3):231-4. doi: 10.1007/BF02987867.
6
[Percutaneous transhepatic portal vein embolization for hepatocellular carcinoma].经皮肝门静脉栓塞治疗肝细胞癌
Nihon Geka Gakkai Zasshi. 1998 Apr;99(4):234-40.
7
Changes in hepatic lobe volume in hepatocellular carcinoma after transcatheter arterial and percutaneous transhepatic portal embolization.经导管动脉栓塞术和经皮经肝门静脉栓塞术后肝细胞癌肝叶体积的变化
Hepatogastroenterology. 2004 Nov-Dec;51(60):1820-4.
8
Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.门静脉栓塞与门静脉结扎用于诱导未来肝剩余体积增大的比较
J Gastrointest Surg. 2002 Nov-Dec;6(6):905-13; discussion 913. doi: 10.1016/s1091-255x(02)00122-1.
9
Preoperative portal vein embolization for major liver resection: a meta-analysis.肝大部切除术前门静脉栓塞术:一项荟萃分析
Ann Surg. 2008 Jan;247(1):49-57. doi: 10.1097/SLA.0b013e31815f6e5b.
10
Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.门静脉结扎术作为在结直肠癌肝转移外科治疗中增加未来肝剩余体积的一种有效方法。
Arch Surg. 2008 Oct;143(10):978-82; discussion 982. doi: 10.1001/archsurg.143.10.978.

引用本文的文献

1
The Guidelines for Percutaneous Transhepatic Portal Vein Embolization: English Version.经皮经肝门静脉栓塞术指南:英文版
Interv Radiol (Higashimatsuyama). 2024 Mar 1;9(1):41-48. doi: 10.22575/interventionalradiology.2022-0031.
2
Right portal vein ligation is still relevant for left hemi-liver hypertrophy: results of a comparative study using a propensity score between right portal vein ligation and embolization.右门静脉结扎术对于左半肝肥大仍然具有相关性:使用倾向评分对右门静脉结扎术和栓塞术进行比较研究的结果。
Langenbecks Arch Surg. 2023 Dec 29;409(1):25. doi: 10.1007/s00423-023-03213-8.
3
Portal vein embolization in extended liver resection.扩大肝切除术中的门静脉栓塞术
Langenbecks Arch Surg. 2017 Aug;402(5):727-735. doi: 10.1007/s00423-017-1591-8. Epub 2017 May 31.
4
Tumour growth of colorectal rat liver metastases is inhibited by hepatic arterial infusion of the mTOR-inhibitor temsirolimus after portal branch ligation.门静脉分支结扎后,经肝动脉输注mTOR抑制剂替西罗莫司可抑制大鼠结直肠癌肝转移灶的肿瘤生长。
Clin Exp Metastasis. 2015 Apr;32(4):313-21. doi: 10.1007/s10585-015-9707-4. Epub 2015 Feb 19.
5
Bismuth classification is associated with the requirement for multiple biliary drainage in preoperative patients with malignant perihilar biliary stricture.对于术前伴有恶性肝门部胆管狭窄的患者,铋剂分类与多次胆汁引流的需求相关。
Surg Endosc. 2015 Jul;29(7):1862-70. doi: 10.1007/s00464-014-3878-y. Epub 2014 Oct 3.
6
Is there new hope for patients with marginally resectable liver malignancies.边缘可切除肝恶性肿瘤患者是否有新的希望?
World J Gastrointest Surg. 2012 Jul 27;4(7):163-5. doi: 10.4240/wjgs.v4.i7.163.

本文引用的文献

1
RELATION OF THE PORTAL BLOOD TO LIVER MAINTENANCE : A DEMONSTRATION OF LIVER ATROPHY CONDITIONAL ON COMPENSATION.门脉血液与肝脏维护的关系:肝脏萎缩条件补偿的论证。
J Exp Med. 1920 Apr 30;31(5):609-32. doi: 10.1084/jem.31.5.609.
2
Volumetric and functional recovery of the remnant liver after major liver resection with prior portal vein embolization : recovery after PVE and liver resection.门静脉栓塞术前大肝切除术后残肝的体积和功能恢复:门静脉栓塞术和肝切除术后的恢复情况
J Gastrointest Surg. 2009 Aug;13(8):1464-9. doi: 10.1007/s11605-009-0929-0. Epub 2009 May 28.
3
Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival.伴或不伴门静脉栓塞的肝细胞癌肝大部切除术:围手术期结局与生存情况
Surgery. 2009 Apr;145(4):399-405. doi: 10.1016/j.surg.2008.10.009.
4
Present status and future perspectives of preoperative portal vein embolization.术前门静脉栓塞的现状与未来展望
Am J Surg. 2009 May;197(5):686-90. doi: 10.1016/j.amjsurg.2008.04.022. Epub 2009 Feb 27.
5
Effect of portal vein embolisation on the growth rate of colorectal liver metastases.门静脉栓塞对结直肠癌肝转移瘤生长速率的影响。
Br J Cancer. 2009 Feb 24;100(4):617-22. doi: 10.1038/sj.bjc.6604872. Epub 2009 Feb 10.
6
Improved hepatocyte function of future liver remnant of cirrhotic rats after portal vein ligation: a bonus other than volume shifting.门静脉结扎后肝硬化大鼠未来肝残余的肝细胞功能改善:除了体积变化之外的额外益处。
Surgery. 2009 Feb;145(2):202-11. doi: 10.1016/j.surg.2008.10.006.
7
Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases.门静脉结扎的两阶段肝切除术(R0)——旨在治愈广泛性双叶结直肠癌肝转移患者。
Int J Colorectal Dis. 2009 Apr;24(4):409-18. doi: 10.1007/s00384-008-0620-z. Epub 2008 Dec 16.
8
Induction of tumor growth after preoperative portal vein embolization: is it a real problem?术前门静脉栓塞后肿瘤生长的诱导:这是一个实际问题吗?
Ann Surg Oncol. 2009 Feb;16(2):423-30. doi: 10.1245/s10434-008-0222-6. Epub 2008 Dec 3.
9
Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.门静脉结扎术作为在结直肠癌肝转移外科治疗中增加未来肝剩余体积的一种有效方法。
Arch Surg. 2008 Oct;143(10):978-82; discussion 982. doi: 10.1001/archsurg.143.10.978.
10
Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor?结直肠癌肝转移的大肝切除术:术前门静脉阻断是肿瘤学危险因素吗?
Ann Surg Oncol. 2008 Jul;15(7):1908-17. doi: 10.1245/s10434-008-9925-y. Epub 2008 May 6.

经皮经肝门静脉栓塞术与单侧门静脉结扎术的比较。

Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation.

机构信息

Department of Surgery, Meiwa Hospital 4-31 Agenaruo-cho, Nisinomiya, Hyogo 663-8186, Japan.

出版信息

World J Gastroenterol. 2012 May 21;18(19):2371-6. doi: 10.3748/wjg.v18.i19.2371.

DOI:10.3748/wjg.v18.i19.2371
PMID:22654428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3353371/
Abstract

AIM

To compare the effect of percutaneous transhepatic portal vein embolization (PTPE) and unilateral portal vein ligation (PVL) on hepatic hemodynamics and right hepatic lobe (RHL) atrophy.

METHODS

Between March 2005 and March 2009, 13 cases were selected for PTPE (n = 9) and PVL (n = 4) in the RHL. The PTPE group included hilar bile duct carcinoma (n = 2), intrahepatic cholangiocarcinoma (n = 2), hepatocellular carcinoma (n = 2) and liver metastasis (n = 3). The PVL group included hepatocellular carcinoma (n = 2) and liver metastasis (n = 2). In addition, observation of postoperative hepatic hemodynamics obtained from computed tomography and Doppler ultrasonography was compared between the two groups.

RESULTS

Mean ages in the two groups were 58.9 ± 2.9 years (PVL group) vs 69.7 ± 3.2 years (PTPE group), which was a significant difference (P = 0.0002). Among the indicators of liver function, including serum albumin, serum bilirubin, aspartate aminotransferase, alanine aminotransferase, platelets and indocyanine green retention rate at 15 min, no significant differences were observed between the two groups. Preoperative RHL volumes in the PTPE and PVL groups were estimated to be 804.9 ± 181.1 mL and 813.3 ± 129.7 mL, respectively, with volume rates of 68.9% ± 2.8% and 69.2% ± 4.2%, respectively. There were no significant differences in RHL volumes (P = 0.83) and RHL volume rates (P = 0.94), respectively. At 1 mo after PTPE or PVL, postoperative RHL volumes in the PTPE and PVL groups were estimated to be 638.4 ± 153.6 mL and 749.8 ± 121.9 mL, respectively, with no significant difference (P = 0.14). Postoperative RHL volume rates in the PTPE and PVL groups were estimated to be 54.6% ± 4.2% and 63.7% ± 3.9%, respectively, which was a significant difference (P = 0.0056). At 1 mo after the operation, the liver volume atrophy rate was 14.3% ± 2.3% in the PTPE group and 5.4% ± 1.6% in the PVL group, which was a significant difference (P = 0.0061).

CONCLUSION

PTPE is a more effective procedure than PVL because PTPE is able to occlude completely the portal branch throughout the right peripheral vein.

摘要

目的

比较经皮经肝门静脉栓塞术(PTPE)和单侧门静脉结扎术(PVL)对肝血流动力学和右肝叶(RHL)萎缩的影响。

方法

2005 年 3 月至 2009 年 3 月,我们选择了 13 例 RHL 行 PTPE(n=9)和 PVL(n=4)。PTPE 组包括肝门胆管癌(n=2)、肝内胆管细胞癌(n=2)、肝细胞癌(n=2)和肝转移瘤(n=3)。PVL 组包括肝细胞癌(n=2)和肝转移瘤(n=2)。此外,比较了两组术后 CT 和多普勒超声检查获得的肝血流动力学观察结果。

结果

两组的平均年龄分别为 58.9±2.9 岁(PVL 组)和 69.7±3.2 岁(PTPE 组),差异有统计学意义(P=0.0002)。在肝功能指标方面,包括血清白蛋白、血清胆红素、天冬氨酸转氨酶、丙氨酸转氨酶、血小板和吲哚菁绿 15 分钟潴留率,两组间无显著差异。PTPE 和 PVL 组术前 RHL 体积估计分别为 804.9±181.1 mL 和 813.3±129.7 mL,体积率分别为 68.9%±2.8%和 69.2%±4.2%,RHL 体积(P=0.83)和 RHL 体积率(P=0.94)无显著差异。PTPE 或 PVL 术后 1 个月,PTPE 和 PVL 组的术后 RHL 体积估计分别为 638.4±153.6 mL 和 749.8±121.9 mL,无显著差异(P=0.14)。PTPE 和 PVL 组术后 RHL 体积率估计分别为 54.6%±4.2%和 63.7%±3.9%,差异有统计学意义(P=0.0056)。术后 1 个月,PTPE 组肝萎缩率为 14.3%±2.3%,PVL 组为 5.4%±1.6%,差异有统计学意义(P=0.0061)。

结论

PTPE 比 PVL 更有效,因为 PTPE 能够完全闭塞右外周静脉的门静脉分支。